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Abstract
Background: At least twenty genes/loci were shown to be associated with type 2diabetes in European original 
populations. Five of these genes were shown to be associated with type 2 diabetes (T2D) in Chinese populations. The 
purpose of this study was to replicate the association of genetic vairants in the eight diabetes-related genes/loci with 
type 2 diabetes in a Han Chinese cohort from western part of China. Nineteen single nucleotide polymorphisms (SNPs) 
from the eight genes/loci including TCF7L2, HHEX, CDKAL1, SLC30A8, PPARG, IGF2BP2, KCNJ11, and CDKN2A/CDKN2B were 
genotyped in 1,529 cases and 1,439 controls in a Han Chinese population using the ABI SNaPshot method. The meta-
analysis of the association between rs7903146 in TCF7L2 gene and T2D in the Han Chinese was performed.
Results: Among the eight genes/loci examined, we found that four were significantly associated with T2D. Although 
previous studies showed that the association between the SNP rs7903146 in the TCF7L2 gene and T2D was 
controversial within the Han Chinese population, we have confirmed the significant association between the SNP 
rs7903146 in the TCF7L2 gene and T2D in both this study and the meta-analysis in the population. In addition, we also 
confirmed that three SNPs (rs1111875, rs7923837 and rs5015480) in HHEX , one SNP (rs10946398) in CDKAL1, and three 
SNPs (rs13266634, rs3802177 and rs11558471) in SLC30A8 were significantly associated with T2D in the population 
being studied.
Conclusions: We demonstrated that the variants in TCF7L2, CDKAL1, HHEX, and SLC30A8 genes are associated with T2D 
in a Han Chinese population.
Background
Diabetes is characterized as hyperglycemia that occurs
when the pancreas does not produce enough insulin, or
when the body cannot effectively use the insulin it pro-
duces. Globally, diabetes causes about 5% of all deaths
each year; this statistic is likely to increase by more than
50% in the next ten years without urgent action http://
www.who.int/diabetes/en. In China, it is estimated that
the number of diabetes patients will increase from the
previous figure of 20.8 million in 2000, to 42.3 million in
2030 [1]. Type 2 diabetes (T2D) is the most common
form of diabetes, which is caused by an interaction of
multiple genes and environmental factors.
Previous linkage studies and candidate gene
approaches have identified several genes associated with
T2DM, such as CAPN10, ENPP1, HNF4A, ACDC,
PPARG, and KCNJ11 [2-8]. The TCF7L2 gene, initially
mapped by a linkage study, is the strongest known T2D
association gene in European original populations [9].
Whole genome association studies (WGAS) offer a new
approach to gene discovery for T2D. For example, genetic
variants in more than 15 genes/loci including CDKN2A/
B, CDKAL1, SLC30A8, IGF2BP2, HHEX/IDE, FTO,
KCN1, NOTCH2, CDC123/CAMK1D, ADAMTS9,
THADA, TSPAN8/LGR5, JAZF1, MTNR1B and IRS
genes, have been showed to be associated with T2D by
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Although more and more T2D associated gene/loci are
being identified, the replication study has played a critical
role in confirming the reported T2D associated genes/
loci, especially within different ethnic populations.
Among the T2D genes/loci, single nucleotide polymor-
phisms (SNPs) in CDKAL1, CDKN2A/B, IGF2BP2,
SLC30A8, and HHEX/IDE genes were also shown to have
an association with T2D in two Chinese cohorts [20-23].
The association between rs7903146 in the TCF7L2 and
T2D in the Chinese population is still considered to be
controversial in Han Chinese populations from north,
east and south China [24-27]. In this study, we examined
the associations of nineteen SNPs in eight T2D genes/loci
in a Han Chinese population in western part of China.
Methods
Subjects
This study was approved by the Clinical Research Ethics
Committee of the Sichuan Academy of Medical Sciences
& Sichuan Provincial People's Hospital. All subjects pro-
vided informed consent prior to participation in the
study. Diabetes patients were recruited in the diabetes
clinic at Sichuan Academy of Medical Sciences & Sichuan
Provincial People's Hospital. Included were 1,529 diabetic
cases and 1,439 non-diabetic controls. Diabetes was diag-
nosed in accordance with the criteria of the World Health
Organization [28]. There was not exposure to glucose-
lowering treatment for the controls, controls with a fast-
ing plasma glucose concentration <5.6 mmol were
enrolled from the same geographical region. The age of
the patients, body mass index (BMI), SBP, DBP, GLU, TC,
TG, LDL, HDL, HbA1c, and duration of T2D were
recorded. All cases and controls were Han Chinese from
Chengdu area of China. The basic characteristics of the
cases and controls are listed in Table 1.
Genotyping
The Han Chinese series of 1,529 diabetic patients was
genotyped and allele frequencies were compared to 1,439
ethnicity-matched non-diabetic control subjects by lab
personnel blinded to case/control status. The DNA was
isolated from white blood cells using the phenol/chloro-
form and ethanol precipitation method. SNPs in eight
genes/loci from the first round of European GWASs were
analyzed in this study, most significant SNPs in the
GWASs or in the replication studies in East Asians were
selected to perform genotyping. Nineteen SNPs in eight
genes/loci were genotyped using the ABI SNapShot
method (Applied Biosystem, CA, USA). In brief, PCR was
performed using specific PCR primers; the specific
SNaPshot primer was used for a SNaPshot reaction using
the purified PCR products as templates. The SNaPshot
reaction products were then analyzed on an ABI 3130
Genetic Analyzer (Applied Biosystem, CA, USA). All
PCR and SNaPshot primers are listed in Additional file 1.
To confirm the genotyping results, 10% of the samples
were randomly selected and re-genotyped by direct
sequencing using a BigDye terminator (Applied Biosys-
tem, CA, USA); no more than a 2% discrepancy was
observed in all SNPs between the two genotyping meth-
ods.
Statistical Analysis
Continuous variables were described as mean ± std (  ±
s) or quartiles (P25, M, and P75) for data with and without
normality, respectively, and were tested by a Student t-
test. Categorical variables such as gender (male vs.
female) were analyzed using a Chi-square test.
We tested the Hardy-Weinberg equilibrium (HWE) for
each SNP separately in both the case and control popula-
tions by using the Fisher's exact method, as reported by
Emigh, et al. [29]. Linkage disequilibrium (LD) coeffi-
cients (r2 and D') were computed by using Haploview 4.1
http://www.broad.mit.edu/haploview.
A standard chi-square test with a 1-degree-of-freedom
(df) was used to calculate the differences of allele fre-
quencies for each SNP between the case and control
group. Odds ratios (ORs) with 95 percent confidence
intervals (CIs) were assessed for the risk allele of each
SNP based on a multiplicative model. For the genotypes,
we tested a series of genetic models including additive,
dominant/recessive for the SNPs with a p value of < 0.05
of allelic, trend test by using unconditional logistic
regression with adjustment for age, gender, and body
mass index (BMI).
SAS 9.1 (SAS Institute Inc., Cary, NC, USA) was used
to process the data. Results were confirmed by R 2.7.2
http://cran.r-project.org/; a two-sided P value < 0.05 was
considered statistically significant unless stated other-
wise. Different genetic models, including dominant and
recessive model, were evaluated through pearson X2 test
by comparing genotypic counts between cases and con-
trols. Allelic p value is obtained by comparing the allele
frequency difference in cases and controls under the
assumption of a multiplicative model. An additive model
is tested using Armitage's test for a trend [30].
Meta-analysis of the association between rs7903146 in the 
TCF7L2 gene and T2D in the Han Chinese population
We obtained the data for rs7903146 in the TCF7L2 gene
in Han Chinese populations by searching Pub Med using
key words of TCF7L2, Han Chinese, and Diabetes
[21,24,25,31]. Additional four association studies repre-
senting four different parts of China were included in this
meta-analysis. The data was then combined with our data
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under the assumption of a multiplicative model. A total of
3203 cases and 3109 controls of Han Chinese population
for rs7903146 in the TCF7L2 gene were included in this
meta-analysis (Table 2).
Results
We genotyped nineteen representative SNPs in eight
potential T2D genes/loci a Han Chinese population,
comprised of 1,529 cases and 1,429 controls. All SNP
were within Hardy-Weinberg equilibrium in controls (P >
0.05, Table 3). Linkage disequilibrium (LD) analysis of
SNPs genotyped for each gene/locus demonstrated that
SNPs in SCL30A8 and PPARG genes, but not in other
genes, were at the same LD, respectively (Table 3).Three
SNPs in the SCL30A8 gene were at the same LD with D'
of 0.95 to 0.99, but they were not completely at the same
LD because the r2 was less than 0.8 from 0.55 to 0.67.
Three SNPs in the PPARG gene were also showed at the
same LD with D' from 0.7 to 0.89, but they were not
strongly at the same LD because of lower r2 (0.022 to 0.38)
(Table 3).
SNPs in four genes including TCF7L2, CDKAL1,
SLC30A8 and HHEX/IDE showed significant association
with T2D in the studied cohort even after a stringent
Bonferroni correction (adjust p values < 0.05, Table 3).
One SNP (rs7903146) in the TCF7L2 gene, and three
SNPs (rs1111875, rs7923837 and rs5015480) in the
HHEX gene showed significant association with T2D
both in multiplicative and dominant models (adjusted p <
0.027, Table 3). In addition, one SNP (rs10946398) in the
CDKAL1 gene and three SNPs (rs13266634, rs3802177
and rs11558471) in the SLC30A8 gene showed significant
association with T2D in multiplicative, dominant and
recessive models (adjusted p < 0.0026, Table 3). The
rs10946398 in CDKAL1 had the strongest association
with T2D, the frequency of allele T was 0.45 in case sub-
jects and 0.37 in control subjects. Individuals with risk
allele T of rs10946498 conferred a 1.78 fold (95% CI:
1.46~2.17) of increased likelihood of T2D (adjust p = 6.26
× 10-9) with recessive model (Table 3). In the studied
cohort, no association with T2D was found in the typed
SNPs in the four potential T2D genes/loci, including
PPARG, IGF2BP2, KCNJL1, and CDKN2A/B (Table 3).
Meta-analysis of rs7903146 in the TCF7L2 gene with
T2D in four cohorts of Han Chinese populations com-
posed of 3,203 cases and 3,109 controls also supported
that rs7903146 in the TCF7L2 was significantly associ-
ated with T2D in the Han Chinese population (trend p =
6.2 × 10-4) with OR of 1.37.
Discussion
The Chinese population accounts for approximately 20
percent of the world's population. The replication study
of T2D genes/loci in this population has expanded the
genetic investigation of T2D in a large ethnic group. Pre-
vious association studies of genetic variants in the eight
genes and T2D of the Han Chinese populations were
from Hong Kong (south), east and north China. The Chi-
nese population of this study was taken from a Han Chi-
nese population in western part of China. Because
significant differences exist among Han Chinese subpop-
ulations in China [32,33], the population in this study
represented a different type of Han Chinese subpopulala-
Table 1: Characteristics of cases and controls for age and ethnicity
Variables Subject group p value
Cases (n = 1529) Controls (n = 1439)
Age at test (years) 60.2 ± 10.1 58.1 ± 10.8 <0.001
Gender (male %) 47.8 50.0 0.225
BMI (kg/m2) 23.9 ± 2.7 23.5 ± 2.8 <0.001
SBP (mmHg) 136.1 ± 12.0 123.9 ± 16.0 <0.001
DBP (mmHg) 80.04 ± 6.8 76.7 ± 9.3 <0.001
GLU(mmol/L) 8.3 ± 2.7 4.9 ± 0.6 <0.001
TC (mmol/L) 5.22 ± 0.77 5.17 ± 0.87 0.139
TG (mmol/L) 2.09 ± 1.45 1.45 ± 1.14 <0.001
LDL (mmol/L) 3.10 ± 0.85 3.08 ± 0.81 0.497
HDL (mmol/L) 1.40 ± 0.74 1.41 ± 0.30 0.822
HBA1C (%) 7.97 ± 0.73 / /
DURATION ( years) 8.73 ± 4.57 / /


















































Table 2: Meta-analysis of rs7903146 in TCF7L2 with T2D in the Han Chinese populations
Genotyping count Allele frequency Multiplicative model
Authors Samples collected References Cases Controls Risk allele (T)
Total N CC CT TT Total N CC CT TT Case Control p value OR (95% CI)b
Ren et al Beijing (North China) 24 481 438 41 2 491 463 26 2 0.047 0.03 0.063 1.93 (1.13-3.49)
Ng et al Hong Kong (South China) 27 433 408 24 1 419 399 20 0 0.031 0.024 0.17 1.29 (0.90-1.87)
Chang et al Taiwan (East China) 25 760 724 35 1 760 716 44 0 0.024 0.029 0.36 0.81 (0.50-1.31)
Lin et al Chengdu (West China) This study 1529 1348 178 3 1439 1328 107 4 0.060 0.040 0.00038 1.54 (1.21-1.95)
Combined all Han Chinese in China 3203 2918 278 7 3109 2906 197 6 0.046 0.034 0.00058 1.37 (1.15-1.65)


















































Table 3: Association between type 2 diabetes and 19 SNPs in the eight genes/loci
Gene SNP No. LDa D'(r2) P value for HWEb Allel Frequency Additive model
Cases Controls Cases Controls Trend p value Adjusted p value ORc (95% CI)d Adjusted p value OR (95% CI) Adjusted 
p value
OR (95% CI)
TCF7L2 rs6585205 (T) 1 1 vs 2: 0.28 (0.0070) 0.54 0.31 0.43 0.39 0.003 0.055 4.0 × 10-4 1.31 (1.13, 1.53) 0.287 1.11 (0.92, 1.35)
rs7903146 (T) 2 1 vs 3: 0.72 (0.33) 0.25 0.24 0.06 0.04 3.6 × 10-4 0.007 1.54 (1.19, 1.99) 0.001 1.58 (1.25, 2.03) 0.691 1.41 (0.40, 5.02)
rs11196218 (A) 3 2 vs 3: 0.28 (0.01) 0.26 0.60 0.29 0.30 0.520 9.880
HHEX rs1111875 (G) 4 5 vs 4: 0.39 (0.11) 0.11 0.32 0.32 0.28 0.001 0.016 1.11 (0.97, 1.27) 0.005 1.23 (1.07, 1.42) 0.011 1.43 (1.08, 1.89)
rs7923837 (G) 5 5 vs 6: 0.53 (0.18) 0.24 0.99 0.30 0.25 1.4 × 10-5 2.7 × 10-4 1.08 (0.93, 1.25) 8.6 × 10-6 1.39 (1.20, 1.61) 0.062 1.30 (0.99, 1.72)
rs5015480 (C) 6 4 vs 6: 0.69 (0.21) 0.69 0.41 0.21 0.17 0.001 0.027 1.20 (0.96, 1.54) 3.3 × 10-4 1.32 (1.14, 1.54) 0.657 1.08 (0.75, 1.59)
CDKLA1 rs736425 (C) 7 8 vs 9: 0.55 (0.056) 0.48 0.93 0.07 0.07 0.782 14.849
rs10946398 (C) 8 7 vs 8: 0.11 (0.0011) 0.79 0.36 0.45 0.37 1.2 × 10-9 2.2 × 10-8 1.36 (1.20, 1.55) 2.7 × 10-6 1.44 (1.24, 1.68) 6.3 × 10-9 1.78 (1.46, 2.17)
rs4712527 (G) 9 7 vs 9: 0.086 (0.0020) 0.07 0.52 0.22 0.21 0.270 5.132
SCL30A8 rs13266634 (C) 10 10 vs 11 0.99 (0.55) 0.13 0.08 0.59 0.54 1.4 × 10-4 0.003 1.37 (1.20, 1.56) 0.005 1.32 (1.09, 1.60) 0.001 1.31 (1.11, 1.53)
rs3802177 (C) 11 10 vs 12 0.95 (0.64) 0.96 0.15 0.60 0.53 9.9 × 10-8 1.9 × 10-6 1.33 (1.18, 1.52) 0.007 1.29 (1.07, 1.57) 1.2 × 10-8 1.58 (1.35, 1.84)
rs11558471 (A) 12 11 vs 12 0.96 (0.67) 0.96 0.86 0.58 0.52 3.5 × 10-6 6.6 × 10-5 1.25 (1.11, 1.41) 1.7 × 10-4 1.41 (1.18, 1.69) 1.5 × 10-4 1.35 (1.16, 1.59)
PPARG rs180282 (G) 13 13 vs 14: 0.87 (0.079) 0.30 0.78 0.06 0.05 0.394 7.482
rs12636454 (C) 14 14 vs 15: 0.89 (0.38) 0.95 0.81 0.32 0.33 0.523 9.928
rs11128597 (A) 15 13 vs 15: 0.70 (0.022) 0.14 0.43 0.48 0.46 0.296 5.618
IGF2BP2 rs4402960 (T) 16 0.46 0.53 0.23 0.22 0.176 3.335
KCNJ11 rs5215 (C) 17 0.21 0.28 0.42 0.41 0.225 4.277
CDKN2A/ rs564398 (C) 18 18 vs 19 0.12 (0.0011) 0.00 0.27 0.01 0.01 0.627 11.913
CDKN2B rs10811661 (C) 19 0.26 0.56 0.05 0.05 0.880 1.670
a: Linkage disequilibrium (LD), b: Hardy-Weinberg equilibrium, c: Odds ratio (OR), d: Confidence interval (CI).
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supported by the allele frequency differences of SNPs in
the significantly associated T2D genes among Han Chi-
nese subpopulations from different parts of China, for
instance, the C allele frequency of rs1326634 in SCL30A8
gene was 0.59 in cases and 0.54 in controls in this study
compared to 0.42 in cases and 0.47 in controls in the
study by Xiang et al. [23]. Therefore, this study not only
replicated, but also complemented the previous studies of
genetic variants and T2D in the Chinese population.
Although rs7903146 in TCF7L2 was confirmed as the
strongest T2D genetic variant in European original popu-
lations [14], the association of rs7903146 with T2D in
east Asian populations, especially in China, remains
unclear due to the low frequency of the risk allele of
rs7903146 (<5%). Miyake et al. demonstrated that SNP
rs7903146 in the TCF7L2 gene was significantly associ-
ated with T2D in the Japanese population; the adjusted p
value was 0.0011 in a study composed of 1,921 cases and
1,696 controls [14]. In another study dealing with the Jap-
anese population, there was a marginal association
between rs7903146 and T2D. The p value was 0.0485 in a
cohort composed of 1,630 cases and 1,064 controls [34].
Although Chang, et al. did not find a signifcant associa-
tion between rs7903146 and T2D in Taiwan Han Chinese
populaiton study that included a p value of 0.36 (a study
of 760 cases and 760 controls) [25], Maggie, et al. showed
that rs7903146 was significantly associated with T2D in a
Hong Kong Chinese population; the p value was 0.038
with 433 cases and 419 controls [26]. Ren, et al. also indi-
cated that a trend association between rs7903146 and
T2D with a p value of 0.063 in a study of 481 cases and
491 controls [24]. Our results further demonstrated that
rs7903146 in the TCF7L2 gene was significantly associ-
ated with T2D in the Han Chinese population in main-
land China; the T risk allele of rs7903146 conferred a 1.58
fold increasing the likelihood of having T2D, as compared
with individuals who do not carry any of the four risk
alleles (adjusted p = 1.0 × 10-3, dominant model). This
results was also supported by the meta- analysis of the
association between rs7903146 in TCF7L2 gene and T2D
in the four Han Chinese population(Table 2) and in the
East Asian populations [31]. Given the factor of low MAF
(minor allele frequency) of rs7903146 (<5%), and the 5.5%
T2D prevalence in adults in China [26], a power calcula-
tion using an additive genetic model showed that approx-
imately 1,500 cases and 1,500 controls would be
necessary to achieve 80% power for rs7903146. This indi-
cated that the sample size in some of the previous studies
was underpowered in evaluating the association of
rs7903146 and T2D in the Chinese populations
[24,25,27]. Nevertheless, all studies redarding the associa-
tion of TCF7L2 and T2D in Chinese populations indi-
cated that other different genetic variants in the TCF7L2
gene showed a significant association with T2D in Chi-
nese populations [20,24-26]. We also confirmed that
another SNP rs6585205 in TCF7L2 gene was significantly
associated with T2D in the studied cohort with an odd
ratio of 1.31 (adjust p = 4.0 × 10-4, dominant model).
Although it is certain that TCF7L2 plays an important
role in the development of T2D in east Asian popula-
tions, it appears that the contribution of TCF7L12 to T2D
development in east Asian populations is not as strong as
that in Caucasian populations.
Consistent with previous findings [20,21,23,35], we also
confirmed that SNPs in the CDKAL1, HHEX, and
SLC30A8 genes showed a significant association with
T2D in the Han Chinese population being studied. In this
study, we found a significant association between all three
SNPs typed, including rs1111875, rs7923837 and
rs5015480, in the IDE-KIF11-HHEX region, and T2D in
the Chinese population. Among the three SNPs in this
region, rs7923837 showed the most significant associa-
tion with T2D with an odds ratio of 1.39 (adjusted p =
8.62 × 10-6, dominant model). The association is similar
to that previously reported in Chinese populations [21],
which further confirmed that the variants in this region
play an important role in T2D for different races. How-
ever, the frequencies of risk alleles in the three SNPs were
much lower in east Asian populations including China
and Japan, than those reported in European original pop-
ulations.
Among the four T2D associated genes, SNPs in
CDKAL1 and SLC30A8 showed the most significant asso-
ciation with T2D in this study, and the significant associ-
ation between the SNPs of both genes and T2D was
observed all three models (multiplicative, dominant and
recessive models) being tested. Only one SNP rs10946398
among the three SNPs we typed in CDKAL1 showed a
significant association with T2D in this study, however
this SNP showed to have the most significant association
with T2D in all three models (multiplicative, dominant
and recessive models) being tested among all nineteen
SNPs we typed, indicating that the CDKAL1 gene may
contribute more than the other three T2D-related genes
in the development of T2D in Chinese patients being
studied. All three SNPs, including rs13266634, rs3802177
and rs11558471 in the SLC30A8 gene were strongly asso-
ciated with T2D in this study; however, rs3802177 had
the most significant assocaition with T2D among the
three SNPs with an adjusted p value of 1.22 × 10-8 and an
odd ratio of 1.58 when a recessive model was tested. The
SLC30A8 gene plays the second important role among
the four genes/loci in the development of T2D in Chinese
Han population among the four T2D-related genes/loci
in the study. However, these pre-mature conclusions
require further investigaton in different Han Chinese
populations.Although we could not replicate the signifi-
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KCNJ11, EXT2, CDKN2A/B, and LOC387761 genes with
T2D, which can be explained by investigating a different
population in our study. In addition, we cannot exclude
the possibility of the association of other SNPs in these
genes/loci with T2D in the Han Chinese population. Fur-
ther studies regarding other SNPs for these genes in large
Chinese populaiotns are needed to answer these ques-
tions. Because T2D is one of the most common diseases,
and there are many genes invloved in the development of
this disorder, each gene represents a relatively small risk
or protection when they are used to assess a disease
threat in a patient.
Conclusions
We demonstrated that the genetic variants in TCF7L2,
CDKAL1, HHEX, and SLC30A8 were significantly associ-
ated with T2D in a different Han Chinese population
from those of previous studies, further indicating that
these gene/loci may play an important role in the devel-
opment of T2D in the Han Chinese population. We fur-
ther confirmed that TCF7L2 rs7903146 was significant
association with T2D in the Han Chinese population.
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